263 related articles for article (PubMed ID: 28617762)
1. Racial Disparities and Sociodemographic Differences in Incidence and Survival Among Pediatric Patients in the United States With Primary Liver Cancer: A Surveillance, Epidemiology, and End Results (SEER) Population Study.
Nautsch F; Ludwig JM; Xing M; Johnson KM; Kim HS
J Clin Gastroenterol; 2018 Mar; 52(3):262-267. PubMed ID: 28617762
[TBL] [Abstract][Full Text] [Related]
2. Racial and Geographic Disparities in Hepatocellular Carcinoma Outcomes.
Franco RA; Fan Y; Jarosek S; Bae S; Galbraith J
Am J Prev Med; 2018 Nov; 55(5 Suppl 1):S40-S48. PubMed ID: 30670200
[TBL] [Abstract][Full Text] [Related]
3. Risk factors associated with suicide among hepatocellular carcinoma patients: A surveillance, epidemiology, and end results analysis.
Chen C; Jiang Y; Yang F; Cai Q; Liu J; Wu Y; Lin H
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):640-648. PubMed ID: 33051117
[TBL] [Abstract][Full Text] [Related]
4. Impact of sex on the survival of patients with hepatocellular carcinoma: a Surveillance, Epidemiology, and End Results analysis.
Yang D; Hanna DL; Usher J; LoCoco J; Chaudhari P; Lenz HJ; Setiawan VW; El-Khoueiry A
Cancer; 2014 Dec; 120(23):3707-16. PubMed ID: 25081299
[TBL] [Abstract][Full Text] [Related]
5. Disparities in Hepatocellular Carcinoma Incidence, Stage, and Survival: A Large Population-Based Study.
Flores YN; Datta GD; Yang L; Corona E; Devineni D; Glenn BA; Bastani R; May FP
Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1193-1199. PubMed ID: 33737301
[TBL] [Abstract][Full Text] [Related]
6. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
[TBL] [Abstract][Full Text] [Related]
7. Predictors of survival and incidence of hepatoblastoma in the paediatric population.
Allan BJ; Parikh PP; Diaz S; Perez EA; Neville HL; Sola JE
HPB (Oxford); 2013 Oct; 15(10):741-6. PubMed ID: 23600968
[TBL] [Abstract][Full Text] [Related]
8. Incidence and 5-year survival of children and adolescents with hepatoblastoma in the United States.
Kahla JA; Siegel DA; Dai S; Lupo PJ; Foster JH; Scheurer ME; Heczey AA
Pediatr Blood Cancer; 2022 Oct; 69(10):e29763. PubMed ID: 35591805
[TBL] [Abstract][Full Text] [Related]
9. Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival.
Sloane D; Chen H; Howell C
J Natl Med Assoc; 2006 Dec; 98(12):1934-9. PubMed ID: 17225837
[TBL] [Abstract][Full Text] [Related]
10. A review of 218 pediatric cases of hepatocellular carcinoma.
Allan BJ; Wang B; Davis JS; Parikh PP; Perez EA; Neville HL; Sola JE
J Pediatr Surg; 2014 Jan; 49(1):166-71; discussion 171. PubMed ID: 24439603
[TBL] [Abstract][Full Text] [Related]
11. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Race on Survival After Hepatocellular Carcinoma in a Diverse American Population.
Jones PD; Diaz C; Wang D; Gonzalez-Diaz J; Martin P; Kobetz E
Dig Dis Sci; 2018 Feb; 63(2):515-528. PubMed ID: 29275448
[TBL] [Abstract][Full Text] [Related]
13. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States.
Artinyan A; Mailey B; Sanchez-Luege N; Khalili J; Sun CL; Bhatia S; Wagman LD; Nissen N; Colquhoun SD; Kim J
Cancer; 2010 Mar; 116(5):1367-77. PubMed ID: 20101732
[TBL] [Abstract][Full Text] [Related]
14. Childhood liver tumors in Argentina: Incidence trend and survival by treatment center. A report from the national pediatric cancer registry, ROHA network 2000-2015.
Moreno F; Rose A; Chaplin MA; Cipolla MC; García Lombardi M; Nana M; Cervio G; Halac E; Viso M; Ayarzabal V; Bosaleh A; Liberto D; Sarabia E; Rizzi A; Morici M; Streitenberger P; de Dávila MTG
Pediatr Blood Cancer; 2020 Nov; 67(11):e28583. PubMed ID: 32737960
[TBL] [Abstract][Full Text] [Related]
15. Surgical Therapy for Pediatric Hepatoblastoma in the USA over the Last Decade: Analysis of the National Cancer Database.
Kulkarni S; Brauer DG; Turmelle Y; Stoll J; Nadler M; Chapman WC; Doyle MB; Khan AS
J Gastrointest Cancer; 2021 Jun; 52(2):547-556. PubMed ID: 32458263
[TBL] [Abstract][Full Text] [Related]
16. Racial Disparities in Inhospital Outcomes for Hepatocellular Carcinoma in the United States.
Rajbhandari R; Simon RE; Chung RT; Ananthakrishnan AN
Mayo Clin Proc; 2016 Sep; 91(9):1173-82. PubMed ID: 27497857
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.
White DL; Thrift AP; Kanwal F; Davila J; El-Serag HB
Gastroenterology; 2017 Mar; 152(4):812-820.e5. PubMed ID: 27889576
[TBL] [Abstract][Full Text] [Related]
18. Pediatric liver transplantation for hepatocellular cancer and rare liver malignancies: US multicenter and single-center experience (1981-2015).
Vinayak R; Cruz RJ; Ranganathan S; Mohanka R; Mazariegos G; Soltys K; Bond G; Tadros S; Humar A; Marsh JW; Selby RR; Reyes J; Sun Q; Haberman K; Sindhi R
Liver Transpl; 2017 Dec; 23(12):1577-1588. PubMed ID: 28834194
[TBL] [Abstract][Full Text] [Related]
19. Disparities in hepatocellular carcinoma incidence by race/ethnicity and geographic area in California: Implications for prevention.
Yang B; Liu JB; So SK; Han SS; Wang SS; Hertz A; Shariff-Marco S; Lin Gomez S; Rosenberg PS; Nguyen MH; Hsing AW
Cancer; 2018 Sep; 124(17):3551-3559. PubMed ID: 30113700
[TBL] [Abstract][Full Text] [Related]
20. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
Ding J; Wen Z
BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
